Clinical trials
Latent Tuberculosis clinical trials
Below are recruiting latent tuberculosis clinical trials, each written for real people, not researchers. We’re tracking 16 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05756582Recruiting
Screening for hidden TB infection in hospital staff and students
This trial checks hospital workers and certain medical students to see how many have “latent TB,” meaning TB bacteria in the body that may not cause symptoms. The goal is to better understand who might need follow-up and prevention.
RomaAges 18–72 - NCT06033807Recruiting
Screening for hidden TB in school contacts
This study tests a program to find hidden (latent) tuberculosis infections in students who have been close to someone with active TB. It helps identify who might need treatment to prevent them from getting sick later.
Zunyi, GuiyangAges 13 years+ - NCT06728930Enrolling by invitation
New test for diagnosing latent and active TB
This study tests a new type of lab test to find TB bacteria more accurately. It is for people who are being checked for latent (hidden) TB infection, or who have just been diagnosed with active TB. The goal is to see if the new test can help doctors diagnose TB better and faster.
LondonAges 18 years+ - NCT05022862Recruiting
Check how incentives and vDOT help latent TB treatment
This trial studies whether reminder-based “vDOT” and small economic incentives can help people complete treatment for latent (sleeping) tuberculosis. If you have latent TB and are starting a standard medicine plan, it may help you stay on track and finish safely.
Baltimore, MarylandAges 18 years+ - NCT01212003Recruiting
Study of how tuberculosis develops over time
This study follows people with suspected or confirmed tuberculosis (TB), whether they have inactive “latent” TB or active TB. It helps researchers better understand TB’s natural course and may improve future testing and care by allowing collection and storage of samples.
Bethesda, MarylandAges 2–100 - NCT07086820Recruiting
Window prophylaxis for preventing TB in children
This trial tests if a short course of medication can prevent tuberculosis (TB) in children and teenagers who have been in close contact with someone who has active TB. The goal is to see if this approach can stop them from developing the disease.
Calama, AntofagastaAges 5–17 - NCT06022146RecruitingPhase 3
Short TB prevention for school contacts
This trial tests a very short (one-month) medicine course to prevent tuberculosis (TB) in students and school staff who have been exposed to someone with active TB. If you have latent TB infection (the germs are in your body but you're not sick), this treatment aims to stop it from turning into active TB disease.
Anshun, GuiyangAges 13 years+ - NCT06526689Recruiting
Lung health and germs in people exposed to TB
This study looks at how the immune system and natural germs in the lungs work in people who have recently been in close contact with someone with active tuberculosis (TB). It aims to better understand how the body responds to TB exposure.
Oxford, OxfordshireAges 18–65 - NCT06764576Recruiting
Study for people with suspected tuberculosis or related infections
This trial is looking for adults who might have tuberculosis, a related infection called non-tubercular mycobacteriosis, or a hidden (latent) tuberculosis infection. You will provide a sample for testing, and the study will help doctors understand and manage these infections better.
BolognaAges 18 years+ - NCT06751706Enrolling by invitation
Testing blood for TB in patients and their household contacts
This study looks for TB bacteria in the blood of people with active tuberculosis and their close contacts at home. It aims to find better ways to detect TB early and prevent its spread.
KampalaAges 18 years+ - NCT06485895Recruiting
Testing a new TB blood test for diagnosis
This study is testing a new blood test (IGRA) to see if it can help doctors diagnose active and latent (hidden) tuberculosis. If you are already being treated for TB and have had an IGRA blood test, you may be able to join.
MarseilleAges 18 years+ - NCT06498414RecruitingPhase 2/Phase 3
Shorter and safer treatment for latent TB
This trial tests a shorter, safer treatment for people with latent TB infection (TB germs in your body but not making you sick). The goal is to prevent you from getting sick with active TB later.
CotonouAges 5 years+ - NCT06568484RecruitingPhase 2/Phase 3
Preventing TB with bedaquiline in people exposed to TB
This study tests if bedaquiline can prevent tuberculosis (TB) in people who have been in close contact with someone with active TB, including people living with HIV. If you qualify, you would take the study medicine and be monitored to see if it prevents you from developing TB.
UlaanbaatarAges Any age - NCT03474029RecruitingPhase 2/Phase 3
Daily rifapentine treatment test for latent tuberculosis infection
This trial studies whether taking rifapentine every day is safe and helps prevent active tuberculosis (TB) in people who have latent TB infection. It aims to find the best way to stop TB from becoming a serious illness later.
Denver, ColoradoAges Any age - NCT05588492RecruitingPhase 4
Rifamycin treatment to prevent TB after kidney transplant
This study looks at whether a rifamycin-containing medicine plan is safe and effective at preventing latent (hidden) TB after a kidney transplant. If your TB test shows you likely have hidden TB, you would be offered treatment to reduce the chance it becomes active TB.
TaipeiAges 20 years+ - NCT06281834RecruitingPhase 1
Dolutegravir levels with TB prevention in children
This study tests how dolutegravir (an HIV medicine) works in children when taken with weekly rifapentine and isoniazid (medicines to prevent tuberculosis). It may help find the right dose for kids who have HIV and are at risk for TB.
Ibadan, Oyo StateAges 4 weeks–11 years
Hear when a new Latent Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Latent Tuberculosis trials by city
Studies with a site in or near these metro areas.
Common questions
- Are there clinical trials for latent tuberculosis?
- Yes. Clin2 currently lists 16 recruiting latent tuberculosis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a latent tuberculosis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a latent tuberculosis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.